Chronic obstructive pulmonary disease exacerbations in emergency departments: Predictors of outcome

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 2, 2010, Pages 112-117

  Roche, Nicolas ^a   Rabbat, Antoine ^a   Zureik, Mahmoud ^b   Huchon, Gérard ^a  

^a HÔTEL DIEU   (France)

^b INSERM   (France)

Author keywords

Chronic obstructive pulmonary disease; Emergency department; Exacerbations; Prediction, prognosis

Indexed keywords

AGE DISTRIBUTION; APACHE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE EXACERBATION; DISEASE SEVERITY; EMERGENCY WARD; HUMAN; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PROGNOSIS; REVIEW; RISK ASSESSMENT;

BIOLOGICAL MARKERS; EMERGENCY SERVICE, HOSPITAL; HUMANS; LENGTH OF STAY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL;

EID: 76449096155     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328335f039     Document Type: Review

References (33)

1. Donaldson GC, Wilkinson TM, Hurst JR, et al. Exacerbations, and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171:446-452.
2. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:1418-1422.
3. Detournay B, Pribil C, Fournier M, et al. The SCOPE study: health-care consumption related to patients with chronic obstructive pulmonary disease in France. Value Health 2004; 7:168-174.
4. Andersson F, Borg S, Jansson SA, et al. The costs of exacerbations in chronic obstructive pulmonary disease (COPD). Respir Med 2002; 96:700-708.
5. Anzueto A, Leimer I, Kesten S. Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis 2009; 4:245-251.
6. Soler JJ, Martinez-Garcia MA, Roman P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60:925-931.
7. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007; 29:1224-1238.
8. Bourbeau J, Ford G, Zackon H, et al. Impact on patients' health status following early identification of a COPD exacerbation. Eur Respir J 2007; 30:907-913.
9. Langsetmo L, Platt RW, Ernst P, et al. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med 2008; 177:396-401.
10. Ram FS, Wedzicha JA, Wright J, et al. Hospital at home for patients with acute exacerbations of chronic obstructive pulmonary disease: systematic review of evidence. BMJ 2004; 329:315.
11. Bustamante-Fermosel A, Miguel-Yanes JM, Duffort-Falco M, et al. Mortalityrelated factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features. Am J Emerg Med 2007; 25:515-522.
12. Roche N, Zureik M, Soussan D, et al. Predictors of outcomes in COPD exacerbation cases presenting to the emergency department. Eur Respir J 2008; 32:953-961.
13. Dransfield MT, Rowe SM, Johnson JE, et al. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax 2008; 63:301-305.
14. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl JMed 1998; 339:489-497.
15. Ruiz-Gonzalez A, Lacasta D, Ibarz M, et al. C-reactive protein and other predictors of poor outcome in patients hospitalized with exacerbations of chronic obstructive pulmonary disease. Respirology 2008; 13:1028-1033.
16. Connolly MJ, Lowe D, Anstey K, et al. Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: effect of age related factors and service organisation. Thorax 2006; 61:843-848.
17. Piquet J, Maurer C, Barbieux H, et al. Acute exacerbations of COPD admitted to hospital: predictive factors of 3 year mortality. Rev Mal Respir 2007; 24:909-916.
18. Patil SP, Krishnan JA, Lechtzin N, et al. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med 2003; 163:1180-1186.
19. Ucgun I, Metintas M, Moral H, et al. Predictors of hospital outcome and intubation in COPD patients admitted to the respiratory ICU for acute hypercapnic respiratory failure. Respir Med 2006; 100:66-74.
20. Vitacca M, Clini E, Porta R, et al. Acute exacerbations in patients with COPD: predictors of need for mechanical ventilation. Eur Respir J 1996; 9:1487-1493.
21. Brochard L. Noninvasive ventilation for acute exacerbations of COPD: a new standard of care. Thorax 2000; 55:817-818.
22. Carratu P, Bonfitto P, Dragonieri S, et al. Early and late failure of noninvasive ventilation in chronic obstructive pulmonary disease with acute exacerbation. Eur J Clin Invest 2005; 35:404-409.
23. Phua J, Kong K, Lee KH, et al. Noninvasive ventilation in hypercapnic acute respiratory failure due to chronic obstructive pulmonary disease vs. other conditions: effectiveness and predictors of failure. Intensive Care Med 2005; 31:533-539.
24. Tsimogianni AM, Papiris SA, Stathopoulos GT, et al. Predictors of outcome after exacerbation of chronic obstructive pulmonary disease. J Gen Intern Med 2009; 24:1043-1048.
25. Roberts CM, Lowe D, Bucknall CE, et al. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax 2002; 57:137-141.
26. Price LC, Lowe D, Hosker H, et al. The UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admissions for acute COPD exacerbation. Thorax 2006; 61:837-842.
27. Stolz D, Christ-Crain M, Morgenthaler NG, et al. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest 2007; 131:1058-1067.
28. Lomas DA, Silverman EK, Edwards LD, et al. Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax 2008; 63:1058-1063.
29. Lomas DA, Silverman EK, Edwards LD, et al. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J 2009; 34:95-102.
30. Pinto-Plata V, Toso J, Lee K, et al. Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax 2007; 62:595-601.
31. Stolz D, Christ-Crain M, Bingisser R, et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitoninguidance with standard therapy. Chest 2007; 131:9-19.
32. Stolz D, Christ-Crain M, Morgenthaler NG, et al. Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD. Chest 2008; 134:263-272.
33. Stolz D, Breidthardt T, Christ-Crain M, et al. Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD. Chest 2008; 133:1088-1094. (Pubitemid 351685510)